PL1960427T3 - Multimeryczne polipeptydy receptora Fc - Google Patents

Multimeryczne polipeptydy receptora Fc

Info

Publication number
PL1960427T3
PL1960427T3 PL06828004T PL06828004T PL1960427T3 PL 1960427 T3 PL1960427 T3 PL 1960427T3 PL 06828004 T PL06828004 T PL 06828004T PL 06828004 T PL06828004 T PL 06828004T PL 1960427 T3 PL1960427 T3 PL 1960427T3
Authority
PL
Poland
Prior art keywords
protein
polypeptide
multimeric
receptor polypeptides
riia
Prior art date
Application number
PL06828004T
Other languages
English (en)
Inventor
Phillip Mark Hogarth
Bruce David Wines
Original Assignee
Suppremol Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Suppremol Gmbh filed Critical Suppremol Gmbh
Publication of PL1960427T3 publication Critical patent/PL1960427T3/pl

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/70503—Immunoglobulin superfamily
    • C07K14/70535—Fc-receptors, e.g. CD16, CD32, CD64 (CD2314/705F)
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/06—Linear peptides containing only normal peptide links having 5 to 11 amino acids
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/50—Immunoglobulins specific features characterized by immunoglobulin fragments
    • C07K2317/52—Constant or Fc region; Isotype
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/30—Non-immunoglobulin-derived peptide or protein having an immunoglobulin constant or Fc region, or a fragment thereof, attached thereto
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/32—Fusion polypeptide fusions with soluble part of a cell surface receptor, "decoy receptors"

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Immunology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Transplantation (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Cell Biology (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
PL06828004T 2005-12-13 2006-12-13 Multimeryczne polipeptydy receptora Fc PL1960427T3 (pl)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US75030105P 2005-12-13 2005-12-13
PCT/AU2006/001890 WO2007068047A1 (en) 2005-12-13 2006-12-13 Multimeric fc receptor polypeptides
EP06828004A EP1960427B1 (en) 2005-12-13 2006-12-13 Multimeric fc receptor polypeptides

Publications (1)

Publication Number Publication Date
PL1960427T3 true PL1960427T3 (pl) 2011-07-29

Family

ID=38162476

Family Applications (1)

Application Number Title Priority Date Filing Date
PL06828004T PL1960427T3 (pl) 2005-12-13 2006-12-13 Multimeryczne polipeptydy receptora Fc

Country Status (7)

Country Link
EP (1) EP1960427B1 (pl)
AT (1) ATE499384T1 (pl)
DE (1) DE602006020333D1 (pl)
ES (1) ES2359218T3 (pl)
PL (1) PL1960427T3 (pl)
PT (1) PT1960427E (pl)
WO (1) WO2007068047A1 (pl)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2005221187B2 (en) 2004-03-10 2011-09-01 Trinity Therapeutics, Inc. Method for inhibiting immune complex formation in a subjetc
BRPI0721078A2 (pt) * 2006-12-13 2014-10-07 Suppremol Gmbh POLIPEPTÍDEOS DE RECEPTORES Fc MULTIMÉRICOS INCLUINDO UM DOMÍNIO Fc MODIFICADO
WO2009023777A2 (en) * 2007-08-14 2009-02-19 Trinity Therapeutics, Inc. Methods for treating immune thrombocytopenia
AU2009270805B2 (en) 2008-07-18 2016-11-03 Trinity Therapeutics, Inc. Methods for treating immune-mediated dengue fever infections and antibody-dependent enhancement of dengue fever infections, including dengue hemorrhagic fever and dengue shock syndrome
US10028998B2 (en) 2012-10-30 2018-07-24 Suppremol Gmbh Method for treating an inflammatory disease and/or an autoimmune disease with a soluble FcγRIIb
US10669324B2 (en) 2012-10-30 2020-06-02 Suppremol Gmbh Vector encoding an Fc gamma receptor IIB protein and composition of the encoded protein
AU2012244302B2 (en) * 2012-10-31 2014-08-21 Suppremol Gmbh A method for treating or preventing either one or both of an inflammatory disease and an autoimmune disease
EP2796144A1 (en) * 2013-04-26 2014-10-29 SuppreMol GmbH Highly concentrated Formulations of soluble Fc receptors
EP2837637A1 (en) 2013-08-16 2015-02-18 SuppreMol GmbH Novel anti-FcyRIIB IgG-type antibody

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1991006570A1 (en) * 1989-10-25 1991-05-16 The University Of Melbourne HYBRID Fc RECEPTOR MOLECULES
CA2512974A1 (en) 2003-01-13 2004-07-29 Macrogenics, Inc. Soluble fc.gamma.r fusion proteins and methods of use thereof

Also Published As

Publication number Publication date
ATE499384T1 (de) 2011-03-15
EP1960427B1 (en) 2011-02-23
EP1960427A4 (en) 2009-03-04
WO2007068047A1 (en) 2007-06-21
ES2359218T3 (es) 2011-05-19
PT1960427E (pt) 2011-03-22
DE602006020333D1 (de) 2011-04-07
EP1960427A1 (en) 2008-08-27

Similar Documents

Publication Publication Date Title
WO2006118772A3 (en) Fcrn antibodies and uses thereof
EA200901436A1 (ru) Антигенсвязывающие белки, связывающие par-2
JOP20190017B1 (ar) أجسام مضادة ترتبط مع مستقبل cgrp بشري
EA200801621A1 (ru) Антитела, направленные на her-3, и их применение
MX353319B (es) Composiciones y metodos relacionados con anticuerpos del receptor de glucagon.
MX2009012950A (es) ANTICUERPOS HUMANIZADOS CONTRA EL GLOBULOMERO Aß (20-42) Y SUS USOS.
MX2009002571A (es) Anticuerpos anti-activina a y usos de los mismos.
NO20083712L (no) Peptider som blokkerer bindingen av IGG til FCRN
EA201270634A1 (ru) АНТИГЕНСВЯЗЫВАЮЩИЕ БЕЛКИ ЧЕЛОВЕКА, КОТОРЫЕ СВЯЗЫВАЮТСЯ С β-КЛОТО, РЕЦЕПТОРАМИ FGF И ИХ КОМПЛЕКСАМИ
NO20062087L (no) Bispesifikt antistoff som substituerer for funksjonelle proteiner
EA200700136A1 (ru) Анти-cd154-антитела
MX2008000030A (es) Metodos para el tratamiento de enfermedad autoinmune utilizando anticuerpos anti-cd16a humanizados.
WO2006073941A3 (en) Polypeptides that bind br3 and uses thereof
TW200732350A (en) Methods for generating monovalent IgG
TW200639181A (en) Antigen binding molecules that bind EGFR, vectors encoding same, and uses thereof
MA40882B1 (fr) Molécules de liaison d'antigène comprenant un trimère de ligand de la famille tnf
TW200738748A (en) Human monoclonal antibody human CD134 (OX40) and methods of making and using same
EA201071126A1 (ru) Антагонисты рецепторов глюкагона
MA34004B1 (fr) Protéines de liaison à cd127
WO2006029224A3 (en) Methods of using death receptor ligands and cd20 antibodies
EP1960427A4 (en) MULTIMED FC RECEPTOR POLYPEPTIDES
WO2006117782A3 (en) Recombinant antibodies against cd55 and cd59 and uses thereof
PL1709073T3 (pl) Substancja wiążąca receptor IIb Fc ludzkiej IgG (FcγRIIb)
MX2008000230A (es) Proteinas de enlace il-6.
DK1711531T3 (da) Neutraliserende anti-TLR4/-MD-2-antistoffer og fremgangsmåder til anvendelse deraf